pharma

Summary : –  Growing body of evidence validates Vir’s approach of targeting a highly conserved region of the spike protein – Together…

Bioretec Ltd a globally operating Finnish medical device company, announced that the company has submitted an application for the CE mark for…

Summary : -Biocon Biologics Ltd, said its partner Viatris has won favourable decisions from a US federal court in Sanofi’s challenge over…

Summary : This loan facility is the Company’s first green loan facility. The term and revolving loans under this facility are priced…

Summary : Merck, known as MSD outside the United States and Canada, and Eisai announced that the Japanese Ministry of Health, Labour…

Synopsis: Alembic Pharma share price fell over 4 percent in intraday trade on December 16 following reports that the US Food and…

Synopsis: The EMA’s human medicines committee has said it cannot approve Biogen and Eisai’s Alzheimer’s disease therapy Aduhelm, saying it was unconvinced…

Summary : The company will invest up ₹6 crore for the 33% stake in the target firm Cipla on Wednesday announced that…

Summary – The European Medicines Agency (EMA) has issued a list of about 100 regulatory science topics that need further research to close…

Synopsis- Under the extended contract, the dedicated R&D center, ‘Syngene Amgen Research and Development Center’ (SARC), will continue to conduct drug discovery…